Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V9ZG
|
||||
| Former ID |
DIB010919
|
||||
| Drug Name |
Cetraxate
|
||||
| Synonyms |
Neuer; NeuerCap; NeuerS; Cetraxate hydrochloride; DV-1006
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Peptic ulcer [ICD9: 531-534; ICD10:K25-K27] | Approved | [551871] | ||
| Company |
Daiichi Seiyaku Co Ltd
|
||||
| Formula |
C17H23NO4
|
||||
| Canonical SMILES |
C(=O)(Oc1ccc(CCC(=O)O)cc1)[C@@H]1CC[C@H](CC1)CN
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Kallikrein | Target Info | Modulator | [533503], [551871] | |
| References | |||||
| Ref 533503 | A new broad spectrum inhibitor of esteroproteases, 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006). Tohoku J Exp Med. 1972 Mar;106(3):233-48. | ||||
| Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.